当前对Diamond-Blackfan贫血的理解与治疗展望
本文综述Diamond-Blackfan贫血(DBA)的发病机制与治疗进展,指出其由核糖体蛋白基因杂合变异及非核糖体蛋白基因(如GATA1、TSR2)异常所致,p53激活、翻译功能障碍、炎症、珠蛋白/血红素合成失衡和自噬失调参与红系生成受损;主要治疗为糖皮质激素,但半数患者长期治疗后无反应需输血,造血干细胞移植是唯一治愈手段但受供者限制和免疫并发症制约,慢病毒载体基因治疗在RPS19缺陷DBA中显示促进正常造血的希望。
要点
- DBA主要由核糖体蛋白基因杂合变异引起,GATA1、TSR2等非核糖体蛋白基因亦相关。
- 糖皮质激素是主要治疗,但半数患者长期治疗后无反应需输血。
- 造血干细胞移植是唯一治愈手段,受供者可用性和严重免疫并发症限制。
核心结论
- 随着对DBA分子框架认识的深入,基因治疗等新兴疗法有望提供治愈方案并增进对疾病机制的理解。
研究设计与样本
- 本文为综述,未报告检索范围或纳入研究数量。
主要发现
- DBA是一种以红系发育不良为特征的罕见先天性骨髓衰竭性疾病,主要影响婴儿,常由核糖体蛋白(RP)基因杂合等位变异引起。
- 近期研究提示GATA1、TSR2等非RP基因也与DBA相关。
- p53激活、翻译功能障碍、炎症、珠蛋白/血红素合成失衡和自噬失调被显示参与红系生成 disrupted 和红细胞生成受损。
- DBA患者的主要治疗选择是糖皮质激素,但半数患者长期治疗后对糖皮质激素治疗无反应,不得不接受输血。
- 造血干细胞移植是目前唯一的治愈选择,但受合适供者可用性和潜在严重免疫并发症的限制。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Diamond-Blackfan anemia (DBA) is a rare congenital bone marrow failure disorder characterized by erythroid hypoplasia. It primarily affects infants and is often caused by heterozygous allelic variations in ribosomal protein (RP) genes. Recent studies also indicated that non-RP genes like GATA1, TSR2, are associated with DBA. P53 activation, translational dysfunction, inflammation, imbalanced globin/heme synthesis, and autophagy dysregulation were shown to contribute to disrupted erythropoiesis and impaired red blood cell production. The main therapeutic option for DBA patients is corticosteroids. However, half of these patients become non-responsive to corticosteroid therapy over prolonged treatment and have to be given blood transfusions. Hematopoietic stem cell transplantation is currently the sole curative option, however, the treatment is limited by the availability of suitable donors and the potential for serious immunological complications. Recent advances in gene therapy using lentiviral vectors have shown promise in treating RPS19-deficient DBA by promoting normal hematopoiesis. With deepening insights into the molecular framework of DBA, emerging therapies like gene therapy hold promise for providing curative solutions and advancing comprehension of the underlying disease mechanisms.
引用
- Liu Y, Karlsson S. Perspectives of current understanding and therapeutics of Diamond-Blackfan anemia. Leukemia. 2023. PMID: 37973818. doi:10.1038/s41375-023-02082-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。